Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer

Catégorie d'article: Research Article

Publié en ligne: 07 avr. 2022

Pages: 185 - 197

Reçu: 26 sept. 2021

Accepté: 28 janv. 2022

DOI: https://doi.org/10.2478/raon-2022-0012

Mots clés

vactosertib, transforming growth factor-β (TGF-β), radiotherapy, epithelial-to-mesenchymal transition, cancer stem cell, breast cancer

© 2022 Jiwon Choi, Jiyoung Park, Ilyoung Cho, Yhunyhong Sheen, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.